PharmaShots | Incisive News in 3 Shots

Subscribe Now

Targeted Indication

CStone Signs an Out-Licensing Agreement with EQRx for Sugemalimab and CS1003

CStone Signs an Out-Licensing Agreement with EQRx for Sugemalimab and CS1003

October 27, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us